They have reported that NF‐κB activation in astrocytes led to significant upregulation of Wnt5a, which acted on microglia to increase their proliferation, delaying the presymptomatic phase of ALS, but greatly increasing the severity of the symptomatic stage [34, 64]. Here, NFKB1 is linked to amyotrophic lateral sclerosis.